Skip to main content

Table 1 Patient characteristics during the study period (N = 417). Cochran-Armitage test for trend

From: Clinical and echocardiographic trends in percutaneous balloon mitral valvuloplasty

Patient characteristics

1990–1999

(N = 165)

2000–2009

(N = 182)

2010–2019

(N = 70)

P-value

(test trend)

Age-adjusted

Age (Mean ± SD years)

(Median; range)

57.7 ± 10.8

(57; 28–84)

55.3 ± 11.0

(56; 23–88)

55.1 ± 11.3

(54; 29–80)

.09

Sex (female)

139 (84.2)

147 (80.8)

48 (69.6)

.02

.02

Obesity (BMI > 30)

79 (48.2)

71 (39.2)

29 (41.4)

.19

.27

Smoking

48 (29.8)

68 (37.8)

37 (52.9)

.001

.001

Hypertension

66 (40.5)

81 (45.3)

38 (54.3)

.06

.02

Dyslipidemia

69 (42.1)

80 (45.2)

40 (58.0)

.04

.02

Diabetes mellitus

44 (27.0)

43 (24.2)

22 (31.1)

.64

.11

Chronic kidney failure

22 (13.6)

26 (14.7)

24 (34.8)

.001

.001

Ischemic heart disease

45 (27.6)

49 (27.7)

28 (40.6)

.10

.01

CABG

7 (4.3)

10 (5.6)

6 (9.0)

.19

.20

Atrial fibrillation

79 (48.2)

92 (50.5)

40 (57.1)

.24

.63

Stroke

21 (13.0)

26 (14.4)

10 (14.7)

.68

.74

Endocarditis

6 (3.8)

3 (1.7)

1 (1.5)

.21

.27

  1. CABG coronary artery bypass graft